跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,603 条关于
“Jiangsu Hengrui Pharmaceuticals Co.”
全部
19,603
临床试验
3,213
药物
2,642
机构
3,180
资讯
10,568
2个月前
Glenmark Advances Phase 3 Trial of Trastuzumab Rezetecan in Platinum-Resistant Ovarian Cancer Following DCGI Approval
去年
FDA Approves Single-Dose Paclitaxel Biosimilar for Metastatic Breast Cancer
8个月前
Global Clinical Trials Landscape Shows Strong Activity in Gout and Bronchiectasis Research
去年
Mycovia Pharmaceuticals Initiates Phase 2 Trial of Oteseconazole for Cryptococcal Meningitis
去年
FDA Clears IND for IDEAYA's Novel DLL3-Targeting Antibody Drug Conjugate IDE849 for Solid Tumors
去年
Pacira BioSciences Settles EXPAREL Patent Litigation with Fresenius Kabi, Securing Market Exclusivity Until 2030
去年
Sandoz Launches Generic Paclitaxel for Metastatic Breast Cancer Treatment
6个月前
Merck KGaA Deepens China Investment with €170 Million Manufacturing Expansion and Drug Development Partnership
去年
Chinese Drugmaker Jiangsu Hengrui Becomes World's Top Clinical Trial Sponsor as China Transforms Global R&D Landscape
去年
Hengrui Pharmaceuticals Aims to Raise $1.27 Billion in Hong Kong IPO
第 1 页，共 1057 页
上一页
下一页
